These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8481548)

  • 1. Audit of the change from twice daily to basal-bolus insulin regimens in insulin-dependent diabetes.
    Baxter MA; Wright AD
    J Diabetes Complications; 1993; 7(1):34-8. PubMed ID: 8481548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Wang C; Mamza J; Idris I
    Diabet Med; 2015 May; 32(5):585-94. PubMed ID: 25594251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterioration in blood glucose control in females with diabetes changed to a basal-bolus regimen using a pen-injector.
    Hardy KJ; Jones KE; Gill GV
    Diabet Med; 1991 Jan; 8(1):69-71. PubMed ID: 1826248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premixed vs basal-bolus insulin regimen in Type 2 diabetes: comparison of clinical outcomes from randomized controlled trials and real-world data.
    Anyanwagu U; Mamza J; Gordon J; Donnelly R; Idris I
    Diabet Med; 2017 Dec; 34(12):1728-1736. PubMed ID: 28945928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Rosenstock J; Park G; Zimmerman J;
    Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of insulin detemir in Japanese children with type 1 diabetes.
    Jinno K; Urakami T; Horikawa R; Kawamura T; Kikuchi N; Kikuchi T; Kizu R; Kosaka K; Mizuno H; Mochizuki T; Nishii A; Ohki Y; Soneda S; Sugihara S; Tatematsu T; Amemiya S;
    Pediatr Int; 2012 Dec; 54(6):773-9. PubMed ID: 22726205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens.
    Davies RR; McEwen J; Moreland TA; Durnin C; Newton RW
    Diabet Med; 1988 Oct; 5(7):671-5. PubMed ID: 2975553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two intensified conventional insulin regimens with three and four daily injections.
    Faglia E; Favales F; Brivio M; Calia P; Quarantiello A
    Diabete Metab; 1993; 19(6):575-81. PubMed ID: 8026609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Injection site for quick-acting insulin. Significance for glycemic control in basal bolus insulin regimen].
    Henriksen JE; Djurhuus MS; Vaag AA; Thye-Rønn P; Knudsen DU; Nielsen OH; Beck-Nielsen H
    Ugeskr Laeger; 1994 Aug; 156(35):4976-9. PubMed ID: 7992431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison between basal insulin glargine and NPH insulin in patients with diabetes type 1 on conventional intensive insulin therapy].
    Pesić M; Zivić S; Radenković S; Velojić M; Dimić D; Antić S
    Vojnosanit Pregl; 2007 Apr; 64(4):247-52. PubMed ID: 17580534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update).
    Philis-Tsimikas A
    Expert Opin Pharmacother; 2008 Aug; 9(12):2181-95. PubMed ID: 18671472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey.
    Evans M; Jensen HH; Bøgelund M; Gundgaard J; Chubb B; Khunti K
    J Med Econ; 2013 Nov; 16(11):1357-65. PubMed ID: 24111563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic insulin aspart given thrice daily is as efficacious as a basal-bolus insulin regimen with four daily injections: a randomised open-label parallel group four months comparison in patients with type 2 diabetes.
    Ligthelm RJ; Mouritzen U; Lynggaard H; Landin-Olsson M; Fox C; le Devehat C; Romero E; Liebl A
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):511-9. PubMed ID: 17115349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
    Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
    Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basal bolus therapy in adolescent diabetic patients].
    Steinemann MA; Zuppinger K
    Ther Umsch; 1990 Jan; 47(1):22-9. PubMed ID: 2408179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal-bolus insulin therapy in Type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin.
    Herz M; Arora V; Sun B; Ferguson SC; Bolli GB; Frier BM
    Diabet Med; 2002 Nov; 19(11):917-23. PubMed ID: 12421428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.